Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 10 | 113165610 | missense variant | C/A | snv | 5.3E-02 | 2.9E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2008 | 2008 | ||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.200 | 10 | 113164066 | intron variant | C/T | snv | 0.20 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 10 | 113156827 | intron variant | G/T | snv | 0.52 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 10 | 113154906 | intron variant | C/T | snv | 0.71 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.882 | 0.160 | 10 | 113154906 | intron variant | C/T | snv | 0.71 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.882 | 0.160 | 10 | 113154906 | intron variant | C/T | snv | 0.71 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
10 | 113153211 | intron variant | C/T | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 10 | 113152371 | synonymous variant | C/T | snv | 2.8E-05 | 2.1E-05 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.080 | 10 | 113151879 | missense variant | C/T | snv | 7.0E-06 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.080 | 10 | 113151879 | missense variant | C/T | snv | 7.0E-06 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.040 | 10 | 113151854 | synonymous variant | C/T | snv | 1.6E-05 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.040 | 10 | 113151107 | missense variant | G/A | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||
|
0.925 | 0.040 | 10 | 113151107 | missense variant | G/A | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2002 | 2002 | ||||||
|
0.925 | 0.040 | 10 | 113151107 | missense variant | G/A | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||
|
0.776 | 0.280 | 10 | 113149972 | intron variant | C/T | snv | 0.16 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.100 | 0.667 | 15 | 2007 | 2015 | |||||||
|
0.776 | 0.280 | 10 | 113149972 | intron variant | C/T | snv | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2010 | 2012 | |||||||
|
0.776 | 0.280 | 10 | 113149972 | intron variant | C/T | snv | 0.16 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |